The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

JCN Chan, LL Lim, NJ Wareham, JE Shaw, TJ Orchard… - The Lancet, 2020 - thelancet.com
Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

Antioxidant effects of statins by modulating Nrf2 and Nrf2/HO-1 signaling in different diseases

A Mansouri, Ž Reiner, M Ruscica… - Journal of clinical …, 2022 - mdpi.com
Statins are competitive inhibitors of hydroxymethylglutaryl-CoA (HMG-CoA) reductase and
have been used to treat elevated low-density lipoprotein cholesterol (LDL-C) for almost four …

[HTML][HTML] Consolidated health economic evaluation reporting standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation …

D Husereau, M Drummond, S Petrou, C Carswell… - Value in health, 2013 - Elsevier
Background Economic evaluations of health interventions pose a particular challenge for
reporting because substantial information must be conveyed to allow scrutiny of study …

[HTML][HTML] Inter-society consensus for the management of peripheral arterial disease (TASC II)

L Norgren, WR Hiatt, JA Dormandy, MR Nehler… - Journal of vascular …, 2007 - Elsevier
The Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral
Arterial Disease (TASC) was published in January 2000 1-3 as a result of cooperation …

[BUCH][B] Applied methods of cost-effectiveness analysis in healthcare

AM Gray, PM Clarke, JL Wolstenholme, S Wordsworth - 2010 - books.google.com
The third volume in the Handbooks in Health Economic Evaluation series, this book
provides the reader with a comprehensive set of instructions and examples of how to …

† Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text‡: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of …

L Ryden, E Standl, M Bartnik, GV Berghe… - European heart …, 2007 - academic.oup.com
1Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text23 | European
Heart Journal Supplements | Oxford Academic Skip to Main Content Advertisement Oxford …

[HTML][HTML] Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with …

Heart Protection Study Collaborative Group - Journal of vascular surgery, 2007 - Elsevier
OBJECTIVES: The Heart Protection Study (HPS) provides an opportunity to assess directly
the effects of cholesterol-lowering therapy on major vascular events (defined as myocardial …

Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting

S Petrou, A Gray - Bmj, 2011 - bmj.com
RESEARCH METHODS & REPORTING Page 1 Economic evaluation using decision analytical
modelling: design, conduct, analysis, and reporting Evidence relating to healthcare decisions …

Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis

J Afilalo, G Duque, R Steele, JW Jukema… - Journal of the American …, 2008 - jacc.org
Objectives: This study was designed to determine whether statins reduce all-cause mortality
in elderly patients with coronary heart disease. Background: Statins continue to be …

Lipid‐lowering for peripheral arterial disease of the lower limb

PP Aung, H Maxwell, RG Jepson… - Cochrane Database …, 2007 - cochranelibrary.com
Background Lipid‐lowering therapy is recommended for secondary prevention in people
with coronary artery disease. It may also reduce cardiovascular events and/or local disease …